Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris
- 31 March 1981
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 101 (4) , 380-385
- https://doi.org/10.1016/0002-8703(81)90125-3
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Atenolol: once-daily cardioselective beta blockade for angina pectoris.Circulation, 1980
- MetoprololNew England Journal of Medicine, 1979
- Angina Pectoris and the Placebo EffectNew England Journal of Medicine, 1979
- AtenololDrugs, 1979
- Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.Circulation, 1979
- Long‐Term Clinical Experience with Atenolol—a New Selective β‐1‐Blocker with Few Side‐Effects from the Central Nervous SystemActa Medica Scandinavica, 1979
- Atenolol in the Treatment of Angina PectorisActa Medica Scandinavica, 1977
- Effect of atenolol on ventilatory and cardiac function in asthma.BMJ, 1976
- Clinical Pharmacokinetics of β-Adrenoreceptor Blocking DrugsClinical Pharmacokinetics, 1976
- Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.BMJ, 1975